BioCentury
ARTICLE | Company News

J&J, Cardinal Health deal

March 16, 2015 7:00 AM UTC

Johnson & Johnson’s Ethicon Inc. subsidiary will sell its Cordis cardiology and endovascular devices company to Cardinal Health for $1.9 billion in cash. Cardinal expects the purchase to be accretive ...